Biotech

All Articles

Metsera coordinate with Amneal to lock down GLP-1 supply

.Along with very early period 1 data now out in the wild, metabolic condition ensemble Metsera is ac...

Rivus articles records to back up muscle-sparing excessive weight medication cases

.Rivus Pharmaceuticals has unveiled the information behind its own period 2 being overweight succeed...

BMS spends $110M to form T-cell therapy deal, aiding Excellent acquire opportunity to improve prioritized pipeline

.Bristol Myers Squibb is actually paying for Prime Medication $110 thousand upfront to develop reage...

Generate increases one more $1B-plus Big Pharma partnership

.Novartis has tattooed a bargain possibly worth more than $1 billion with Flagship-founded Generate:...

Metsera GLP-1 records slice discloses 7.5% effective weight loss at 36 days

.Recently debuted Metsera is actually unfolding some phase 1 data for its own GLP-1 receptor agonist...

Flagship wishes biotechs group to Mirai to increase genetic meds

.Surrounded by the genetic medications arms nationality, Crown jewel Pioneering is introducing a new...

BioAge eyes $180M from IPO, private positioning for being overweight trials

.BioAge Labs is checking out all around $180 million in initial profits from an IPO and also a perso...

Merck's LAG-3 combination fails intestines cancer phase 3 research study

.A try through Merck &amp Co. to uncover the microsatellite dependable (MSS) metastatic colon cancer...

Spanish VC shuts $200M lifestyle sciences fund

.Spain-based Asabys Allies has finalized a fund of 180 million europeans ($ 200 thousand), money tha...

BioAge generates $198M from IPO as weight problems biotech participates in Nasdaq

.BioAge Labs is generating nearly $200 million using its own Nasdaq IPO this morning, along with the...